Ginolis
Oulunsalo
About Ginolis
Ginolis, established in 2010 and headquartered in Oulu, Finland, specializes in providing advanced automation solutions for the medical device and diagnostics industries.The company offers modular robotic systems designed for the efficient manufacturing of multiplex assays, lateral flow point-of-care tests, and consumables for medical devices. Emphasizing a compact, modular, and scalable approach, Ginolis's desktop automation systems occupy a smaller footprint compared to traditional setups, optimizing valuable production space. This modularity allows for easy reconfiguration to adapt to evolving manufacturing needs, while scalability enables clients to invest incrementally and expand production capacity as demand grows. With a global presence, including offices in the USA, Ginolis collaborates with many of the world's leading diagnostic companies. The company's mission is to provide efficient and high-quality manufacturing solutions for rapid diagnostic tests and medical devices, ultimately contributing to more effective healthcare worldwide. Ginolis aims to be one of the leading global systems suppliers in the diagnostics industry to enable the shift to automated production.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series Unknown (Feb 2017)
- Website: ginolis.com
- Phone: +358 10 315 3600
Industries & Categories
Industrial Automation, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ginolis-3051070 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.